{"url_path":"/sec/goss/8-k/2026-07-15/item-9-01","section_key":"item-9-01","section_title":"Item 9.01 Financial Statements and Exhibits.","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-07-15","source_url":"https://www.sec.gov/Archives/edgar/data/1728117/0001728117-26-000061-index.html","accession_number":"0001728117-26-000061","cik":"0001728117","ticker":"GOSS","issuer_name":"Gossamer Bio, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1728117/0001728117-26-000061-index.html","primary_entity_key":"0001728117","primary_entity_name":"Gossamer Bio, Inc."},"word_count":104,"has_tables":true,"body_markdown":"Item 9.01 Financial Statements and Exhibits.\n\n(d) Exhibits.\n\nExhibit\nNumberDescription\n\n3.1\n[Certificate of Amendment to the Amended and Restated Certificate of Incorporation of Gossamer Bio, Inc.](goss-20260714xex31xcertifi.htm)\n\n10.1\n[Gossamer Bio, Inc. 2019 Incentive Award Plan, as Amended and Restated Effective May 18, 2026](goss-20260714xex101xrest.htm)\n\n104Cover page interactive data file (embedded with the inline XBRL document)\n\n1\n\nSIGNATURES\n\nPursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.\n\n \n\n  GOSSAMER BIO, INC.\n\n    \n\nDate: July 14, 2026 By:/s/ Christian Waage\n\n  Christian Waage\n\n  Executive Vice President and General Counsel\n\n2"}